Reporting on innovations in global biotech.
Joined August 2014
- Tweets 29,044
- Following 924
- Followers 28,245
- Likes 8,459
15,763 Photos and videos
Jun 12
Not so long ago, DIY biology mostly meant extracting DNA from strawberries or growing mold in a petri dish for a school science project. Those experiments are still around, but the world of amateur biology has evolved considerably over the past decade.
Today, a growing ne...
123
Jun 12
Today we’re diving into the world of corticosteroids and hormonal therapies, essential APIs that treat everything from asthma and autoimmune diseases to diabetes and endocrine disorders. labiotech.eu/podcast/advanci…
108
Jun 10
Discover Daiichi Sankyo's pipeline strategy, including how it aims to become a top-five global oncology company by 2035. labiotech.eu/top-pharma-stra…
81
Jun 10
Find out about some early-stage technologies in neurology that aim to go beyond amyloid, dopamine, and what has dominated the field. labiotech.eu/in-depth/neurol…
90
Spain is emerging as a European pharma and biotech hub, driven by scientific excellence, clinical trial leadership, innovation, and investor appeal. labiotech.eu/partner/pharma-…
98
There were seven multibillion-dollar acquisitions that occurred in May 2026, although it was a quieter month on the biotech deals front. labiotech.eu/trends-news/bio…
92
Today we are delighted to welcome back a very special guest: Joachim Eeckhout, the co-founder of Labiotech, co-owner of Knowbio, and founder of The Science Marketer. labiotech.eu/podcast/episode…
110
Labiotech heard from experts about the major trends and highlights in cancer care at ASCO 2026. labiotech.eu/trends-news/asc…
76
We look at how rising acquisitions in the life science industry are being driven by patent cliffs. labiotech.eu/trends-news/sur…
99
Explore the future of cell and gene therapies in China as it adopts a new piece of regulation that might change strategies. labiotech.eu/in-depth/china-…
129
May 29
Find out about how biotech companies are trying to address the limits the first generation of WEE1 inhibitors faced. labiotech.eu/in-depth/wee1-i…
87
May 29
Today we welcome Dr. Daniel Vitt, CEO of Immunic Therapeutics. With World MS Day tomorrow 30th of May, this is the perfect moment to focus on multiple sclerosis. labiotech.eu/podcast/world-m…
2
92
May 28
Discover how Lab Thread unifies fragmented life science data into one platform to streamline workflows, collaboration, and research. labiotech.eu/partner/lab-thr…
78
May 27
Novel ways to discover undruggable protein targets are paving way for the next wave of proximity degraders. labiotech.eu/in-depth/proxim…
1
77
May 25
Bayer has a lot on its plate; lawsuits, patent cliffs, drug development, and potential FDA approvals. Is it ready to make a comeback in 2026? labiotech.eu/top-pharma-stra…
166
May 22
This week, the 2026 LSX Nordic Congress was held in Copenhagen. Find out what came out of the Nordic-focused partnering event. labiotech.eu/trends-news/lsx…
103
May 22
Our two guests this week: Quin Wills, CEO of Ochre Bio, and Stéphane Barges, CEO of Lexogen. labiotech.eu/podcast/the-pro…
108
May 20
For nearly thirty years, there have been no FDA-approved drugs for pattern hair loss, but this could change soon as therapies near approval. labiotech.eu/trends-news/pat…
88
May 20
As Sweden's life sciences sector continues to grow, we explore 8 biotech companies in Sweden that are leading the way in the industry. labiotech.eu/best-biotech/bi…
77
May 19
Delve into the field of RAS inhibitors, an area of biotechnology that is increasingly diversifying to tackle pancreatic cancer, among other cancers. labiotech.eu/in-depth/ras-in…
108